{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:59:59Z","timestamp":1778659199508,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.tcm.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T06:46:53Z","timestamp":1380696413000},"page":"142-148","source":"Crossref","is-referenced-by-count":32,"title":["Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition"],"prefix":"10.1016","volume":"24","author":[{"given":"Francesco","family":"Violi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2013.09.006_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ahj.2005.10.006","article-title":"Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease\u2014A randomized, placebo-controlled study","volume":"151","author":"Alber","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1016\/j.tcm.2013.09.006_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1016\/j.tcm.2013.09.006_bib3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/ATVBAHA.111.227959","article-title":"Anoxia-reoxygenation enhances platelet thromboxane A2 production via reactive oxygen species-generated NOX2: effect in patients undergoing elective percutaneous coronary intervention","volume":"31","author":"Basili","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9150(02)00387-8","article-title":"Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation","volume":"167","author":"Bea","year":"2003","journal-title":"Atherosclerosis"},{"issue":"A7\u20138","key":"10.1016\/j.tcm.2013.09.006_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(01)01597-1","article-title":"Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease","volume":"88","author":"Blann","year":"2001","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.tcm.2013.09.006_bib6","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1172\/JCI26869","article-title":"Minding the gaps to promote thrombus growth and stability","volume":"115","author":"Brass","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.tcm.2013.09.006_bib7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/db11-1243","article-title":"Platelet isoprostane overproduction in diabetic patients treated with aspirin","volume":"61","author":"Cangemi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tcm.2013.09.006_bib8","doi-asserted-by":"crossref","first-page":"e000198","DOI":"10.1161\/JAHA.113.000198","article-title":"Relationship between platelet and urinary 8-Iso-PGF2alpha levels in subjects with different degrees of NOX2 regulation","volume":"2","author":"Carnevale","year":"2013","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.tcm.2013.09.006_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1538-7836.2011.04558.x","article-title":"Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers","volume":"10","author":"Carnevale","year":"2012","journal-title":"Journal of Thrombosis And Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11204600-000000000-00000","article-title":"Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels","volume":"10","author":"Carter","year":"2010","journal-title":"American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions"},{"key":"10.1016\/j.tcm.2013.09.006_bib11","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/bjp.2008.19","article-title":"Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin","volume":"153","author":"Chou","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.tcm.2013.09.006_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","article-title":"Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?","volume":"147","author":"Cotter","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1016\/j.tcm.2013.09.006_bib14","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2013.09.006_bib15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.112.000966","article-title":"Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis","volume":"127","author":"Dayal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0049-3848(91)90010-T","article-title":"Hydrogen peroxide is an intermediate in the platelet activation cascade triggered by collagen, but not by thrombin","volume":"62","author":"Del Principe","year":"1991","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.tcm.2013.09.006_bib17","doi-asserted-by":"crossref","first-page":"23087","DOI":"10.1016\/S0021-9258(19)49429-5","article-title":"Long range propagation of conformational changes in integrin alpha IIb beta 3","volume":"268","author":"Du","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.tcm.2013.09.006_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI30537","article-title":"Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model","volume":"117","author":"Dubois","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.tcm.2013.09.006_bib19","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood-2005-09-3687","article-title":"Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo","volume":"107","author":"Dubois","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2013.09.006_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1160\/TH05-01-0020","article-title":"Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation","volume":"94","author":"Evangelista","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.STR.0000054055.28435.BF","article-title":"Withdrawal of statin treatment abrogates stroke protection in mice","volume":"34","author":"Gertz","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.tcm.2013.09.006_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jnutbio.2010.07.004","article-title":"Effects of resveratrol and other wine polyphenols on vascular function: an update","volume":"22","author":"Gresele","year":"2011","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.tcm.2013.09.006_bib23","first-page":"503","article-title":"Nitric oxide as a unique signaling molecule in the vascular system: a historical overview","volume":"53","author":"Ignarro","year":"2002","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.tcm.2013.09.006_bib24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1067\/mhj.2002.130300","article-title":"Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"144","author":"Istvan","year":"2002","journal-title":"American Heart Journal"},{"key":"10.1016\/j.tcm.2013.09.006_bib25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/CIRCULATIONAHA.110.000034","article-title":"Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo","volume":"123","author":"Jin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.amjmed.2011.04.019","article-title":"Dose-related effect of statins in venous thrombosis risk reduction","volume":"124","author":"Khemasuwan","year":"2011","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.tcm.2013.09.006_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/blood.V100.3.917","article-title":"NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment","volume":"100","author":"Krotz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2013.09.006_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.CIR.95.4.885","article-title":"Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated","volume":"95","author":"Leo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCIMAGING.112.975193","article-title":"Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition","volume":"6","author":"Liu","year":"2013","journal-title":"Circulation. Cardiovascular Imaging"},{"key":"10.1016\/j.tcm.2013.09.006_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCRESAHA.113.301577","article-title":"The identification of nitric oxide as endothelium-derived relaxing factor","volume":"113","author":"Loscalzo","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/j.tcm.2013.09.006_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2009.01.002","article-title":"Statins and cardioprotection\u2014more than just lipid lowering?","volume":"122","author":"Ludman","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.tcm.2013.09.006_bib32","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2005-10-4244","article-title":"Thrombin overcomes the thrombosis defect associated with platelet GPVI\/FcRgamma deficiency","volume":"107","author":"Mangin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2013.09.006_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMcibr021805","article-title":"COX inhibitors and thromboregulation","volume":"347","author":"Marcus","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.tcm.2013.09.006_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI108613","article-title":"Superoxide production and reducing activity in human platelets","volume":"59","author":"Marcus","year":"1977","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.tcm.2013.09.006_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2013.09.006_bib36","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/j.thromres.2013.01.007","article-title":"Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms","volume":"131","author":"Moscardo","year":"2013","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.tcm.2013.09.006_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib38","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1749-6632.1987.tb30994.x","article-title":"The platelet membrane glycoprotein IIb\/IIIa complex. Structure, function, and relationship to adhesive protein receptors in nucleated cells","volume":"509","author":"Phillips","year":"1987","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.tcm.2013.09.006_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/ATVBAHA.109.198622","article-title":"Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia","volume":"30","author":"Pignatelli","year":"2010","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib41","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.bcp.2012.09.011","article-title":"Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation","volume":"84","author":"Pignatelli","year":"2012","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tcm.2013.09.006_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/ATVBAHA.110.217885","article-title":"Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction","volume":"31","author":"Pignatelli","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCULATIONAHA.112.095554","article-title":"Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2","volume":"126","author":"Pignatelli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib44","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2008.03122.x","article-title":"Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance","volume":"6","author":"Pignatelli","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib45","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/blood.V91.2.484","article-title":"Hydrogen peroxide is involved in collagen-induced platelet activation","volume":"91","author":"Pignatelli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2013.09.006_bib46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.0000134963.77201.55","article-title":"gp91phox-dependent expression of platelet CD40 ligand","volume":"110","author":"Pignatelli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2013.09.006_bib47","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1538-7836.2007.02533.x","article-title":"Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin","volume":"5","author":"Pignatelli","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib48","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1074\/jbc.271.25.14916","article-title":"Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms","volume":"271","author":"Pratico","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.tcm.2013.09.006_bib49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.tcm.2013.09.006_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2006.07.026","article-title":"In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment","volume":"194","author":"Pucci","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2013.09.006_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0049-3848(01)00341-3","article-title":"Involvement of NADH\/NADPH oxidase in human platelet ROS production","volume":"103","author":"Seno","year":"2001","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.tcm.2013.09.006_bib52","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.amjcard.2005.11.058","article-title":"Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study)","volume":"97","author":"Serebruany","year":"2006","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.tcm.2013.09.006_bib53","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1538-7836.2005.01403.x","article-title":"Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes","volume":"3","author":"Sommeijer","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib54","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.tcm.2013.09.006_bib55","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1055\/s-0037-1614841","article-title":"Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects","volume":"82","author":"Tannous","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib56","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature: New Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.moh.0000239704.17427.9b","article-title":"Aspirin resistance: is this term meaningful?","volume":"13","author":"Violi","year":"2006","journal-title":"Current Opinion in Hematology"},{"key":"10.1016\/j.tcm.2013.09.006_bib58","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.thromres.2011.12.002","article-title":"Platelet oxidative stress and thrombosis","volume":"129","author":"Violi","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.tcm.2013.09.006_bib59","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/01.ATV.0000229710.13054.2d","article-title":"Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency","volume":"26","author":"Violi","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tcm.2013.09.006_bib60","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1046\/j.1538-7836.2003.00345.x","article-title":"Nitric oxide in vascular biology","volume":"1","author":"Walford","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.tcm.2013.09.006_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/FJC.0b013e318063e820","article-title":"NADPH oxidase inhibitors: new antihypertensive agents?","volume":"50","author":"Williams","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.tcm.2013.09.006_bib62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jacc.2010.04.023","article-title":"Evidence of pre-procedural statin therapy a meta-analysis of randomized trials","volume":"56","author":"Winchester","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.tcm.2013.09.006_bib63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.fjc.0000157456.45691.d4","article-title":"HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats","volume":"45","author":"Yokoyama","year":"2005","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.tcm.2013.09.006_bib64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"The New England Journal of Medicine"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173813001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173813001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T16:12:00Z","timestamp":1646669520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173813001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1050173813001515"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2013.09.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}